Ohio State Navbar

Research

Blow Research Team


   

Most all of us donate to one or more charities.  The goal of giving is to support a worthwhile cause to make a difference in people’s lives.  Through the philanthropy of Warner and Patti Blow the Department, under the guidance of Dr. Frederick Davidorf, has established the Patti Blow Research Team to make a difference in patients with eye cancer.

Last month we celebrated the 10th anniversary of the lab and reviewed many of the accomplishments. Dr. Steven Gabbe, CEO OSU Medical Center, welcomed and thanked the Blows for their support of the Department of Ophthalmology and The Ohio State University College of Medicine.  Researchers from Ophthalmic Oncology, Radiation Oncology, Hematology Oncology, Surgical Oncology, Pathology, and Human Cancer Genetics are part of the multi-disciplined approach to the management of ocular melanomas at Ohio State.

Patients seen on the Ocular Oncology Unit by Dr. Davidorf and Colleen Cebulla, MD, PhD are asked to enroll in the “Melanoma Study.”  The Ocular Melanoma Team studies the molecular genetics of ocular tumors looking for tumor markers that can be used to find and treat early metastatic diseases via target therapy.  This type of therapy is directed toward blocking the rapid growth and spread of circulating melanoma cells. 

Warner acknowledged their many accomplishments and thanked all of the dedicated researchers and staff that have worked so hard over the years and achieve so much.

The goal of their contributions has always been to support basic research with an emphasis on diseases such as diabetic retinopathy, age-related macular degeneration, and melanoma of the eye. 

Now, a decade of results have led us to a more promising future for patients with ocular cancer.  The Blows have made a difference.  We thank them.

TOP RESEARCH MILESTONES

  • Screening natural occurring herbal medicine and effect on melanoma cells in culture
  • Molecular genetic studies in our lab have determined the role of chromosomal abnormalities in the prognosis of patients with ocular melanoma
  • Our researchers under the leadership of Mohammed Abdel-Rahman, PhD have identified a new familial cancer syndrome and an associated abnormal gene
  • Analysis of our patient database has linked ocular melanoma to other malignancies, such as skin melanoma
   
Click here to learn more about Patti & Warner Blow